Literature DB >> 10583607

Acidic pH increases the avidity of FcgammaR for immune complexes.

D H López1, A S Trevani, G Salamone, G Andonegui, S Raiden, M Giordano, J R Geffner.   

Abstract

The interaction of immunoglobulin G (IgG) antibodies with FcgammaR constitutes a critical mechanism through which IgG antibody effector functions are mediated. In the current work we have examined whether human neutrophil FcgammaR exhibit pH dependence in their association with IgG. Binding assays were performed in culture medium adjusted to different pH values. It was found that the binding of either heat-aggregated human IgG (AIgG), soluble immune complexes (sIC) or IgG-coated erythrocytes (IgG-E) was markedly higher at pH 6.5 than at pH 7.3. This effect was not observed when saturation of FcgammaR was achieved, suggesting that acidic pH increases the avidity of FcgammaR for IC without modifying the total binding capacity. Similar results were observed for the binding of AIgG to either monocytes, natural killer (NK) or K562 cells, suggesting that acidic pH increases the avidity of both, FcgammaRII and FcgammaRIII. Additional experiments were performed to analyse whether the binding of IgG to FcgammaRI also showed pH dependence. To this aim, we employed interferon-gamma-treated human neutrophils and mouse inflammatory macrophages, previously incubated with blocking antibodies directed to FcgammaRII and FcgammaRIII. Acidic pH did not enhance the binding of AIgG nor monomeric IgG under these experimental conditions. Further studies are required to determine whether the enhancement of FcgammaR avidity for IC could be attributed to titration of histidine(s) residues on the Fc fragment of IgG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583607      PMCID: PMC2326950          DOI: 10.1046/j.1365-2567.1999.00884.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  Structural bases of Fc gamma receptor functions.

Authors:  W H Fridman; C Bonnerot; M Daeron; S Amigorena; J L Teillaud; C Sautes
Journal:  Immunol Rev       Date:  1992-02       Impact factor: 12.988

Review 2.  Human antibody effector function.

Authors:  D R Burton; J M Woof
Journal:  Adv Immunol       Date:  1992       Impact factor: 3.543

Review 3.  Biology of human immunoglobulin G Fc receptors.

Authors:  J G van de Winkel; C L Anderson
Journal:  J Leukoc Biol       Date:  1991-05       Impact factor: 4.962

Review 4.  Fc receptors.

Authors:  J V Ravetch; J P Kinet
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 5.  The immunoglobulin superfamily--domains for cell surface recognition.

Authors:  A F Williams; A N Barclay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  Activation of human platelets by immune complexes prepared with cationized human IgG.

Authors:  M Schattner; M Lazzari; A S Trevani; E Malchiodi; A C Kempfer; M A Isturiz; J R Geffner
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

7.  Acid pH in tumors and its potential for therapeutic exploitation.

Authors:  I F Tannock; D Rotin
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

8.  The effects of histidine residue modification on the immune precipitating ability of rabbit IgG.

Authors:  R O O'Brien; P J Roeth; S A Thomson; G Bartell; S B Easterbrook-Smith
Journal:  Arch Biochem Biophys       Date:  1994-04       Impact factor: 4.013

9.  The modification of human immunoglobulin binding to staphylococcal protein A using diethylpyrocarbonate.

Authors:  D A Haake; E C Franklin; B Frangione
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

Review 10.  Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.

Authors:  J G van de Winkel; P J Capel
Journal:  Immunol Today       Date:  1993-05
View more
  7 in total

Review 1.  Acidification of the intimal fluid: the perfect storm for atherogenesis.

Authors:  Katariina Öörni; Kristiina Rajamäki; Su Duy Nguyen; Katariina Lähdesmäki; Riia Plihtari; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

2.  Ex vivo TCR-induced leukocyte gene expression of inflammatory mediators is increased in type 1 diabetic patients but not in overweight children.

Authors:  Jaime S Rosa; Masato Mitsuhashi; Stacy R Oliver; Mieko Ogura; Rebecca L Flores; Andria M Pontello; Pietro R Galassetti
Journal:  Diabetes Metab Res Rev       Date:  2010-01       Impact factor: 4.876

3.  An acidic microenvironment increases NK cell killing of Cryptococcus neoformans and Cryptococcus gattii by enhancing perforin degranulation.

Authors:  Anowara Islam; Shu Shun Li; Paul Oykhman; Martina Timm-McCann; Shaunna M Huston; Danuta Stack; Richard F Xiang; Margaret M Kelly; Christopher H Mody
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

Review 4.  pH-responsive antibodies for therapeutic applications.

Authors:  Tomasz Klaus; Sameer Deshmukh
Journal:  J Biomed Sci       Date:  2021-01-22       Impact factor: 8.410

5.  Extracellular Acidification Acts as a Key Modulator of Neutrophil Apoptosis and Functions.

Authors:  Shannan Cao; Peng Liu; Haiyan Zhu; Haiyan Gong; Jianfeng Yao; Yawei Sun; Guangfeng Geng; Tong Wang; Sizhou Feng; Mingzhe Han; Jiaxi Zhou; Yuanfu Xu
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

6.  Autoimmune Disease pH and Temperature.

Authors:  Kevin Carlin
Journal:  J Clin Med Res       Date:  2014-05-22

7.  FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity.

Authors:  Jonathan J Hubbard; Michal Pyzik; Timo Rath; Lisa K Kozicky; Kine M K Sand; Amit K Gandhi; Algirdas Grevys; Stian Foss; Susan C Menzies; Jonathan N Glickman; Edda Fiebiger; Derry C Roopenian; Inger Sandlie; Jan Terje Andersen; Laura M Sly; Kristi Baker; Richard S Blumberg
Journal:  J Exp Med       Date:  2020-10-05       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.